GRAL
GRAIL, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$122.42
+3.91%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 25.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.15x
- Price / sales
- 33.09x
- Price / cash flow
- -18.55x
Enterprise value
- Enterprise value
- $4.7B
- EV / sales
- 28.43x
- EV / EBITDA
- -12.56x
- EV / EBIT
- -8.40x
- Market cap
- $5.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026